Bayer has a long-standing reputation for effective innovation valorization. Next to typical R&D activities, the company has leveraged big on intrapreneurship. Why did they choose to take the path of intrapreneurial programs? How did they manage the constant flow of ideas and scaling intentions? Learn from their most important learnings in managing the innovation portfolio and funnel.
Explore the evolution of sustainability in drug delivery ecosystems, revolutionizing patient care and environmental impact solutions.
How can you leverage digital trends like telemedicine and IoT to accelerate adjacent innovation in your medical devices and projects?
Waiting for the right moment to start developing AI based products? Roy Amara’s Law teaches us that there is no time to waste.